References
- Tai FWD, McAlindon ME. Nonsteroidal anti-inflammatory drugs, and the gastrointestinal tract. Clin. Med. 2021;21:131–134. doi:10.7861/clinmed.2021-0039.
- Graham GG. Fenamates. In: Parnham MJ, editor. Compendium of Inflammatory Diseases. Basel: Springer; 2016. doi:10.1007/978-3-7643-8550-7_24.
- Sharma M, Prasher P. Synthesis, and medicinal applications of fenamic acid derivatives. Curr. Org. Chem. 2023;27:1132–1142. DOI: 10.2174/1385272827666230914113509.
- Prasher P, Fatima R, Sharma M. Targeted delivery with V-amylose. Drug Dev. Res. 2021;82:727–729. DOI: 10.1002/ddr.21804.
- Prasher P, Fatima R, Sharma M. Resistant starch: ideal candidate for enteric coating of NSAIDs? Future Med. Chem. 2021;13:1411–1414. DOI: 10.4155/fmc-2021-0160.
- Fatima R, Sharma M, Prasher P. Targeted delivery of flufenamic acid by V-amylose. Therapeutic Deliv. 2021;12:575–582. DOI: 10.4155/tde-2021-0020.
- Fatima R, Sharma M, Prasher P. Targeted delivery of fenamates with aminated starch. Therapeutic Deliv. 2023;14:183–192. DOI: 10.4155/tde-2023-0013.
- Nouri A, Jelkmann M, Khoee S, Bernkop-Schnürch A. Diaminated starch: a competitor of chitosan with highly mucoadhesive properties due to increased local cationic charge density. Biomacromolecules 2020;21:999–1008. DOI: 10.1021/acs.biomac.9b01665.
- Singh P, Prasher P, Dhillon P, Bhatti R. Indole based peptidomimetics as anti-inflammatory and anti-hyperalgesic agents: dual inhibition of 5-LOX and COX-2 enzymes. Eur. J. Med. Chem. 2015;97:104–123. DOI: 10.1016/j.ejmech.2015.04.044.
- Rasheed A, Kumar CK, Mishra A. Synthesis, hydrolysis studies and phamacodynamic profiles of amide prodrugs of dexibuprofen with amino acids. J. Enzyme Inhib. Med. Chem. 2011;26:688–695. DOI: 10.3109/14756366.2010.548327.
- Cayot P, Tainturier G. The quantification of protein amino groups by the trinitrobenzenesulfonic acid method: a re-examination. Anal. Biochem. 1997;249:184–200. DOI: 10.1006/abio.1997.2161.
- Bina A, Raissi H, Hashemzadeh H, Farzad F. Conjugation of a smart polymer to doxorubicin through a pH-responsive bond for targeted drug delivery and improving drug loading on graphene oxide. RSC Adv. 2021;11:18809–18817. DOI: 10.1039/d1ra02361f.
- Ansari S, Yamaoka Y. Survival of helicobacter pylori in gastric acidic territory. Helicobacter 2017;22: Article e12386. DOI: 10.1111/hel.12386.
- Skouloubris S, Labigne A, Reuse HD. Identification, and characterization of an aliphatic amidase in Helicobacter pylori. Mol. Microbiol. 1997;25:989–998. DOI: 10.1111/j.1365-2958.1997.mmi536.x.
- Svensson B, Sjostrom H, Noren O. Structural studies on microvillus aminopeptidase from pig small intestine. Eur. J. Biochem. 1982;126:481–488. DOI: 10.1111/j.1432-1033.1982.tb06805.x.
- Tobey N, Heizer W, Yeh R, Huang T-I, Hoffner C. Human intestinal brush border peptidases. Gastroenterology 1985;88:913–926. DOI: 10.1016/s0016-5085(85)80008-1.
- Li X, Zhao C. Zero-order controlled release of water-soluble drugs using a marker pen platform. ACS Omega 2021;6:13774–13778. DOI: 10.1021/acsomega.1c01141.
- Laracuente M-L, Yu MH, McHugh KJ. Zero-order drug delivery: state of the art and prospects. J. Control. Rel. 2020;327:834–856. DOI: 10.1016/j.jconrel.2020.09.020.
- Bisharat L, Barker SA, Narbad A, Craig DQM. In vitro drug release from acetylated high amylose starch-zein films for oral colon-specific drug delivery. Int J Pharm. 2019;556:311–319. DOI: 10.1016/j.ijpharm.2018.12.021.
- Cohen R, Orlova Y, Kovalev M, Ungar Y, Shimoni E. Structural and functional properties of amylose complexes with genistein. J. Agric. Food Chem. 2008;56:4212–4218. DOI: 10.1021/jf800255c.
- Siew LF, Basit AW, Newton JM. The potential of organic-based amylose-ethylcellulose film coatings as oral colon-specific drug delivery systems. AAPS PharmSciTech. 2020;1: Article 22. DOI: 10.1208/pt010322.